Back to Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   Abstract views HTML views PDF downloads Totals
12,743 Dovepress* 7,633 476+ 4,312 8,109
PubMed Central* 15 4,619 1,379 4,634
Totals 7,648 5,095 5,691 12,743
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar